ArticleMolecular therapy. Nucleic acids2022

circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma.

Pengfei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.